off brand tirzepatide Mounjaro, Zepbound: Why two names for the same drug? Stop selling off-brand weight loss
Description
It has also been suggested that hepatic hypoinsulinemia may reduce insulin-like growth factor 1 (IGF-1) levels, which may contribute to IR as well by increasing growth hormone and IGF binding globulins (29)
This is where the story becomes bigger than Cigna
A randomized, placebo-controlled, doubleblind trial [18] compared semaglutide in 5 daily subcutaneous doses (0.05, 0.1, 0.2, 0.3, and 0.4 mg) versus liraglutide 3.0 mg once daily on top of lifestyle changes in obese subjects without diabetes
Conclusion The debate between oral and injectable tirzepatide isnt about which one is better in a vacuum, but which one is better for you
Pharmacology Tirzepatide is a GIP receptor and GLP-1 receptor agonist
Heres where it gets tricky, though
